Three Good Things 2020: a Brief Text-based Wellness Intervention

This trial will be open to all Michigan Medicine Department of Family Medicine faculty, resident, or staff.

The intervention will consist of asking participants the "3 Good Things" based on positive psychology theory. Participants will be asked to list three things that went well that day and to consider their role in these outcomes. Pre and post surveys will be completed to evaluate this intervention.

At the end of the trial the study team will also select a limited number of entries from participants to share some of the "good things" which people listed. These will be edited to ensure writer anonymity and participants will be informed of this plan in the study introduction.

Study Overview

• Status: Completed
• Conditions: Job Related Stress
• Intervention / Treatment: Behavioral: Three Good Things; Behavioral: Wait list control arm and then Three Good Things

• Study Type: Interventional
• Enrollment (Actual): 223
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Michigan
    • Ann Arbor, Michigan, United States, 48109
      • University of Michigan

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Faculty, resident, or staff in the Michigan Medicine (MM) Department of Family Medicine

Exclusion Criteria:

• Not a member of Family Medicine at MM

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Health Services Research
• Allocation: Randomized
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Three Good Things; Three times weekly for three weeks, participants will receive a text-based survey asking them to type or dictate "three good things."	Behavioral: Three Good Things; The treatment phase will last 3 weeks. However, participants will complete surveys at baseline and up to 6 months. At the end of the trial the study team will also select a limited number of entries from participants to share some of the "good things" which people listed. These will be edited to ensure writer anonymity and participants will be informed of this plan in the study introduction.
Active Comparator: Waitlist Control Arm then Three Good Things; Participants will have surveys in the waiting period for 3 months and then be crossed over to the treatment arm Three Good Things.	Behavioral: Wait list control arm and then Three Good Things; Surveys will be completed for 3 months prior to treatment and then after treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in the Positive and Negative Affect Schedule (PANAS-SF) between the intervention and control group	This is a 10 item survey to measure positive and negative affect. Responses include; very slightly or not at all, a little, quite a bit, and extremely. Higher scores of Positive Affect (PA) subscale represent higher positive affect higher scores of Negative affect (NA) subscale represent higher negative affect.	Pre-Treatment (baseline), up to 6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in self-reported physical health	This is a 1 question item to assess participants physical health ( 1=Excellent 2=good 3=fair 4=poor).	Pre-Treatment (baseline), up to 6 months
Change in self-reported mental health	This is a 1 question item to assess participants mental health ( 1=Excellent 2=good 3=fair 4=poor).	Pre-Treatment (baseline), up to 6 months
Change in Gratitude using the Gratitude Adjective Checklist (GAC)	The GAC is a 3-item self-report measure of state gratitude in which participants select, (1) A little (2) Moderately, Quite a bit (4), and Extremely (5).The total score on GAC ranges from 3 to 15, with higher score indicating greater state gratitude.	Pre-Treatment (baseline), up to 6 months
Change in depression using the Patient Health Questionnaire 9-item (PHQ-9) score	PHQ-9 scores reflect depression severity. Participants will select responses that include 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day. Ranges in scores are from 0-27 (Scores: 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe).	Pre-Treatment (baseline) to 6 months
Change in Satisfaction with Life Questionnaire	This is a 5 question questionnaire in which participants select from 7 responses that are given a 1-7 scale from strongly disagree to strongly agree. Scoring ranges from 5-35 where 20 = neutral (the higher the score the more satisfaction).	Pre-Treatment (baseline), up to 6 months
Change in the Hope Scale	This is a 12 item questionnaire in which participants select from answers that include 1=definitely false 2=mostly false 3=mostly true 4=definitely true. Scores range from 12-48 with higher scores indicating greater hope.	Pre-Treatment (baseline), up to 6 months

Collaborators and Investigators

• Sponsor: University of Michigan
• Investigators: Principal Investigator: Katherine Gold, MD, University of Michigan

Study record dates

Study Major Dates

• Study Start (Actual): February 3, 2021
• Primary Completion (Actual): August 28, 2021
• Study Completion (Actual): August 28, 2021

Study Registration Dates

• First Submitted: December 15, 2020
• First Submitted That Met QC Criteria: December 15, 2020
• First Posted (Actual): December 21, 2020

Study Record Updates

• Last Update Posted (Actual): December 3, 2021
• Last Update Submitted That Met QC Criteria: December 2, 2021
• Last Verified: December 1, 2021

More Information

Terms related to this study

• Keywords: Depression; Satisfaction
• Additional Relevant MeSH Terms: Behavioral Symptoms; Stress, Psychological; Occupational Diseases; Occupational Stress
• Other Study ID Numbers: HUM00188399

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No